BioSpace News Archive

Genetown

Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 18, 2023

Psychemedics Corporation announced the grant of inducement awards to its newly appointed President and Chief Executive Officer, Brian Hullinger, upon his entering into employment with the Company in accordance with Nasdaq Listing Rule 5635.

August 18, 2023
·
1 min read
Drug Development

Akari Therapeutics Announces Establishment of Boston U.S. Headquarters Office to Support Expanding Operations and Start of Registrational Phase 3 Clinical Trials

Akari Therapeutics, Plc today announced the establishment of a Boston Seaport area office that is the company’s U.S. headquarters

August 18, 2023
·
4 min read
Business

Satio partners with BARDA DRIVe to develop a novel patch-based ebolavirus diagnostic

Satio is pleased to announce a contract awarded by the Biomedical Advanced Research and Development Authority ( BARDA ), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to develop a novel, single-use, rapid ebolavirus diagnostic.

August 18, 2023
·
2 min read
Medexus Study Supports Efficacy and Safety of IXINITY in Pediatric Patients with Severe or Moderately Severe Hemophilia B

Poster presentation at National Hemophilia Foundation (NHF) Bleeding Disorders Conference 2023 highlights effective prophylaxis, control of bleeding episodes, and consistent safety profile

August 18, 2023
·
9 min read
Clinical Trials Market Size Estimated to Hit USD 83,550 Million by 2032

The global clinical trials market size reached USD 48,680 million in 2022 and is estimated to hit around USD 83,550 million by 2032, expanding at a CAGR of 5.6% from 2023 to 2032, As per the study by Towards Healthcare.

August 18, 2023
·
10 min read
Drug Development

Merck Announces WELIREG® (belzutifan) Phase 3 LITESPARK-005 Trial Met Primary Endpoint of Progression-Free Survival in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma

Merck, known as MSD outside of the United States and Canada, announced topline results from LITESPARK-005, the first positive Phase 3 trial investigating WELIREG, Merck’s oral hypoxia-inducible factor-2 alpha inhibitor.

August 18, 2023
·
12 min read
Drug Development

Akeso Announced First Patient Dosed in Phase 3 Trial of Ivonescimab versus Tislelizumab for First-line Treatment of Squamous NSCLC

Akeso Inc. (“Akeso”, 9926. HK) announced today that the first patient has been dosed in a head-to-head phase III trial of ivonescimab, a potential first-in-class investigational PD-1/VEGF bi-specific antibody discovered by Akeso.

August 18, 2023
·
5 min read
Drug Development

Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials

MindBio Therapeutics Corp. is excited to announce it has received its first batch of MB22001 ready for take-home use in Phase 2 psychedelic microdosing clinical trials.

August 18, 2023
·
5 min read
Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. announced today that it will be sponsoring, presenting and hosting a booth at the 15th Annual Next Generation Dx Summit, held virtually and in-person in Washington, D.C. on August 21-23, 2023.

August 18, 2023
·
1 min read
Business

United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023

United Imaging Healthcare, a global innovator in cutting-edge medical imaging and radiotherapy equipment, has unveiled its highly anticipated 2023 half-year report, revealing robust growth.

August 18, 2023
·
2 min read